Literature DB >> 11748791

Cognitive impairment in elderly patients with schizophrenia: age related changes.

P D Harvey1.   

Abstract

Cognitive impairment in schizophrenia is a major feature of the illness. Like many of the other aspects of the illness, however, it has not been studied extensively in older patients. Several studies of older patients with a lifetime course of poor outcome and chronic institutional stay have indicated that some patients manifest evidence of profound cognitive impairments on a cross-sectional basis and cognitive and functional decline over longitudinal follow-ups of 30 months or longer. Risk factors for this decline include lower educational attainment and more severe positive symptoms, but do not include more severe symptoms of physical illness. These impairments have been shown to be discriminable from normal age-related changes and from the changes associated with Alzheimer's Disease. In contrast, studies of patients with no history of lifetime institutional stay find no such evidence of either age-related changes in cognitive functioning or longitudinal decline in cognitive or functional status. Since there is accumulating evidence of progressive brain changes over the lifespan in patients with schizophrenia, the course of cognitive deficits in later life will remain an important topic, both for understanding the lifetime course of schizophrenia and for developing interventions aimed at reduction of disability in the illness. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11748791     DOI: 10.1002/1099-1166(200112)16:1+<::aid-gps565>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

Review 1.  Profiles of neuropsychologic function in schizophrenia.

Authors:  J Daniel Ragland
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Assessment of Lifespan Functioning Attainment (ALFA) scale: A quantitative interview for self-reported current and functional decline in schizophrenia.

Authors:  Jamie Joseph; William S Kremen; Stephen J Glatt; Carol E Franz; Sharon D Chandler; Xiaohua Liu; Barbara K Johnson; Ming T Tsuang; Elizabeth W Twamley
Journal:  J Psychiatr Res       Date:  2015-04-11       Impact factor: 4.791

3.  Characterizing trajectories of cognitive functioning in older adults with schizophrenia: does method matter?

Authors:  Wesley K Thompson; Gauri N Savla; Ipsit V Vahia; Colin A Depp; Ruth O'Hara; Dilip V Jeste; Barton W Palmer
Journal:  Schizophr Res       Date:  2012-12-05       Impact factor: 4.939

Review 4.  Schizophrenia and risk of dementia: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-13       Impact factor: 2.570

5.  Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia.

Authors:  Jan Struyf; Seth Dobrin; David Page
Journal:  BMC Genomics       Date:  2008-11-07       Impact factor: 3.969

6.  Initial Results of Tests Using GSR Biofeedback as a New Neurorehabilitation Technology Complementing Pharmacological Treatment of Patients with Schizophrenia.

Authors:  Renata Markiewicz; Beata Dobrowolska
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.